These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 2635833

  • 1. Role of prostaglandins on lymphocyte transformation in Crohn's disease.
    Echevarría S, Cajigas J, Rodríguez de Lope C, Lozano JL, Pons Romero F.
    Allergol Immunopathol (Madr); 1989; 17(6):317-21. PubMed ID: 2635833
    [Abstract] [Full Text] [Related]

  • 2. Reduced suppressor cell activity in intestinal lymphocytes from patients with Crohn's disease.
    Goodacre RL, Bienenstock J.
    Gastroenterology; 1982 Apr; 82(4):653-8. PubMed ID: 7060886
    [Abstract] [Full Text] [Related]

  • 3. Indomethacin sensitive suppressor cells in Crohn's disease: a possible role in decreased lymphocyte responsiveness.
    Victorino RM.
    J Clin Lab Immunol; 1983 Aug; 11(4):197-201. PubMed ID: 6230454
    [Abstract] [Full Text] [Related]

  • 4. Studies on lymphocyte hyporesponsiveness in cirrhosis: the role of increased monocyte suppressor cell activity.
    Holdstock G, Chastenay BF, Krawitt EL.
    Gastroenterology; 1982 Feb; 82(2):206-12. PubMed ID: 6459260
    [Abstract] [Full Text] [Related]

  • 5. Mitogenic response and interleukin 2 production in Crohn's disease.
    Miura M, Hiwatashi N.
    J Clin Lab Immunol; 1987 Nov; 24(3):113-6. PubMed ID: 3501474
    [Abstract] [Full Text] [Related]

  • 6. Expression of a splice variant of CXCR3 in Crohn's disease patients; indication for a lymphocyte--epithelial cell interaction.
    Manousou P, Kolios G, Drygiannakis I, Pyrovolaki K, Bourikas L, Papadaki HA, Kouroumalis E.
    J Gastroenterol Hepatol; 2008 Dec; 23(12):1823-33. PubMed ID: 18761554
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Induction of T lymphocyte apoptosis by sulphasalazine in patients with Crohn's disease.
    Doering J, Begue B, Lentze MJ, Rieux-Laucat F, Goulet O, Schmitz J, Cerf-Bensussan N, Ruemmele FM.
    Gut; 2004 Nov; 53(11):1632-8. PubMed ID: 15479684
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Mechanism of suppression of the depressed lymphocyte response in lung cancer patients.
    Alberola V, González-Molina A, Trenor A, San Martín B, Lluch A, Palau F, Marín J, García-Conde FJ.
    Allergol Immunopathol (Madr); 1985 Nov; 13(3):213-9. PubMed ID: 2931010
    [Abstract] [Full Text] [Related]

  • 16. Isolation and kinetic characteristics of mucosal lymphocytes in Crohn's Disease.
    Clancy R.
    Gastroenterology; 1976 Feb; 70(2):177-80. PubMed ID: 1082424
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. In vitro effect of indomethacin on mitogen-induced lymphoproliferative response in lung cancer patients.
    Stanojević-Bakić N, Vucković-Dekić L, Susnjar S, Spuzić I.
    Neoplasma; 1992 Feb; 39(2):129-32. PubMed ID: 1326720
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.